Segments covered: By Product – Cell Therapy, Gene Therapy; By Application – Oncology, Dermatology, Musculoskeletal, Others
LONDON, Feb. 23, 2021 (GLOBE NEWSWIRE) -- New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
According to The Business Research Company’s research report on the cell and gene therapy market, the gene therapy market was the largest segment of the cell and gene therapy market segmented by product, accounting for 72.4% of the total in 2020. Going forward, the gene therapy segment is expected to be the fastest growing segment by product, at a CAGR of 30.8% during 2020-2025.
Thus, the top opportunities in the gene cell therapy industry segmented by-product will arise in the gene therapy segment, which will gain $8.97 billion of global annual sales by 2025. The top opportunities in the cell and gene therapy market segmented by the application will arise in the oncology segment, which will gain $6.73 billion of global annual sales by 2025. The cell and gene therapy market size will gain the most in the USA at $3.36 billion.
Genes are the basic physical and functional unit of heredity, received from one’s parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient’s cells to alter the biological property of cells for the treatment of an inherited or acquired disease. It works by several mechanisms, including replacing a disease-causing gene with a healthy copy of the gene, inactivating an ill-functioning disease-causing gene, or introducing a modified gene into the body to treat diseases. On the other hand, cell therapy seeks to treat diseases by altering certain sets of cells. In the cell therapy market, cells which originate from the patient or a donor are modified outside the body and then injected into the patient. This technique replaces dysfunctional cells with functioning ones.
The Business Research Company’s report titled Cell And Gene Therapy Global Market Report 2020-30: COVID-19 Growth And Change covers major cell and gene therapy companies, cell and gene therapy market share by company, cell and gene therapy manufacturers, cell and gene therapy market size, and cell and gene therapy market forecasts. The report also covers the global cell and gene therapy market and its segments.
Request For A Sample Of The Global Cell And Gene Therapy Market Report:
The global cell and gene therapy market reached a value of nearly $4.39 billion in 2020, having increased at a compound annual growth rate (CAGR) of 25.5% since 2015. The market is expected to grow from $4.39 billion in 2020 to $15.48 billion in 2025 at a rate of 28.7%. The market is then expected to grow at a CAGR of 17.3% from 2025 and reach $34.31 billion in 2030.
The global cell and gene therapy market is highly concentrated, with a small number of large players. The top ten competitors in the market made up almost the entire market – up to a 97.46% share of the total market in 2019. Major players in the market include Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals, Inc., and Alnylam Pharmaceuticals, Inc.
Cell And Gene Therapy Global Market Report 2020-30: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, segments and geographies, trends, drivers, restraints, leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports By The Business Research Company:
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
CONTACT: Contact Information The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: firstname.lastname@example.org Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company Follow us on Twitter: https://twitter.com/tbrc_info